Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Learn what customers are saying about no annual fee travel credit cards. Gain insights to help you choose the right card for your travels.
22,936 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Choosing the right growth ETF means weighing stability against potential upside. This guide compares Vanguard VONG an...
A veteran wealth manager makes a bold move into defense stocks as geopolitical tensions rise. Learn the strategy, ris...
XRP has long been tied to a grand bridge-currency dream. This article presents a bull case that even skeptics should ...
Iren has closed a $3 billion convertible notes sale at a 1% coupon, due 2033, to bankroll its AI cloud infrastructure...
Oil’s sharp moves in early 2026 push investors toward stock-based plays that mimic commodity exposure without futures...
Palantir shares moved higher as market chatter tied the AI and national security agenda to politics. Investors weigh ...
Institutional appetite for BTC is reshaping retirement planning. Analysts say a measured, long-term approach could me...
As tax rules and market conditions shift in 2026, retirees with $2M in retirement accounts seek to preserve wealth. T...
GlobalFoundries stock skyrocketed this week as quantum computing initiatives and government backing boosted optimism....
As inflation lingers and policy shifts loom, traders weigh a defensive, dividend-heavy pick trading under $50 against...
Abercrombie & Fitch shares surged after a stronger-than-expected quarter. This article breaks down the factors behind...